A Study to Assess Safety and Pharmacokinetics of Telaprevir in Patients With Hepatic Impairment

NCT01600976 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatic Impairment

Interventions

DRUG: telaprevir

Sponsor

Janssen Infectious Diseases BVBA